Solventum Corporation (SOLV) EPS CAGR:223.00%(TTM)
EPS CAGR uses precomputed diluted earnings history where available.
Over longer horizons, Solventum Corporation's EPS CAGR averages 4.70% over 3 years and 6.26% over 5 years.The TTM figure compares the trailing 12 months (sum of the latest four quarters) with the 12 months before that. Rows in the history table compare fiscal years, and the quarterly table compares single quarters; the three measure different windows and will differ. EPS (Earnings Per Share) CAGR measures how Solventum Corporation's earnings per share have grown. This is a key metric for valuation and reflects profitability on a per-share basis.
SOLV EPS CAGR Chart
Solventum Corporation (SOLV)
SOLV Quarterly EPS Growth (YoY)
EPS growth vs the same quarter one year earlier, last 13 quarters.
SOLV EPS CAGR History
| Year | Start EPS | End EPS | Change | % Change | CAGR |
|---|---|---|---|---|---|
| 2025 | $2.77 | $8.94 | +$6.17 | +222.74% | +222.74% |
| 2024 | $7.79 | $2.77 | $-5.02 | -64.46% | -64.46% |
| 2023 | $7.79 | $7.79 | +$0.00 | +0.04% | +0.04% |
| 2022 | $8.47 | $7.79 | $-0.68 | -8.03% | -8.03% |
| 2021 | $6.60 | $8.47 | +$1.87 | +28.33% | +28.33% |
Quarterly EPS: QoQ & YoY
| Quarter | Value | QoQ | YoY |
|---|---|---|---|
| Q1 2026 | $0.07 | -80.6% | -91.1% |
| Q4 2025 | $0.36 | -95.0% | +100.0% |
| Q3 2025 | $7.26 | +1296.2% | +937.1% |
| Q2 2025 | $0.52 | -34.2% | +2.0% |
| Q1 2025 | $0.79 | +338.9% | -42.3% |
| Q4 2024 | $0.18 | -74.3% | -88.6% |
| Q3 2024 | $0.70 | +37.3% | -73.7% |
| Q2 2024 | $0.51 | -62.8% | -72.6% |
| Q1 2024 | $1.37 | -13.0% | -19.2% |
| Q4 2023 | $1.57 | -40.9% | -11.5% |
| Q3 2023 | $2.66 | +43.3% | +37.3% |
| Q2 2023 | $1.86 | +9.6% | -8.4% |
| Q1 2023 | $1.70 | -4.7% | -16.5% |
| Q4 2022 | $1.78 | -8.2% | — |
| Q3 2022 | $1.94 | -4.4% | — |
| Q2 2022 | $2.03 | -0.1% | — |
QoQ = change vs the prior quarter; YoY = change vs the same quarter a year earlier.
About Solventum Corporation
Solventum Corporation, established in 2023 and headquartered in Saint Paul, Minnesota, operates as a healthcare entity dedicated to pioneering, producing, and commercializing diverse solutions that address critical needs for both customers and patients. The company's business activities are organized into four principal segments. The Medsurg division furnishes various products and services, including sophisticated wound care items, intravenous (I.V.) site management tools, sterilization assurance systems, temperature regulation devices, surgical instruments, stethoscopes, and medical electrodes. Its Dental Solutions segment provides a comprehensive range of dental and orthodontic offerings, such as brackets, clear aligners, restorative filling materials, and bonding agents. The Health Information Systems division concentrates on advanced software platforms, covering functionalities like computer-assisted physician documentation, direct billing and coding automation, classification frameworks, voice recognition capabilities, and data visualization tools. Finally, the Purification and Filtration segment supplies an array of purification and filtration technologies, including various filters, purifiers, cartridges, and specialized membranes.
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- Bryan C. Hanson